Summary
- Current Price
- As of today, CHRS price is $1.13, down -3.42% on
- Current Price All-Time High
- CHRS price is currently -97.03% below its historical high of $38.10 set on
- Market Cap
- CHRS current market cap is $175M, up +3.60% over the past 365 days
- Revenue
- CHRS current annual revenue is $42.17M, up +59.81% year-over-year
- Next Earnings
- The next earnings release for CHRS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Coherus Oncology, Inc. |
| Ticker | NASDAQ: CHRS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | coherus.com |
| Employees | 221 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $1.13 | ||
| Price, 1D Change | -3.42% | |
| $175M | ||
| - | ||
| - | ||
| 1.86 | ||
| $42.17M | ||
| Revenue, 1Y Change | +59.81% | |
| -$1.45 | ||
| EPS, 1Y Change | -12.45% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.45 | ||
| EPS Estimate | -$0.86 | N/A |
| EPS Est. Change | +41.18% | N/A |
| $42.17M | ||
| Revenue Estimate | $60.81M | N/A |
| Revenue Est. Change | +44.19% | N/A |
| $1.13 | ||
| Price Target | $8.50 | - |
| Price Tgt. Change | +652.21% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.86 | -$1.29 | -50.66% | |
| -$1.33 | -$1.45 | -9.30% | |
| -$0.86 | N/A | +41.18% | |
| -$0.63 | N/A | +56.66% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $255.58M | $26.39M | -89.67% | |
| $43.47M | $42.17M | -2.99% | |
| $60.81M | N/A | +44.19% | |
| $100.37M | N/A | +137.99% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -22.07% | ||
| -72.10% | ||
| +3.60% | ||
| -54.36% | ||
| +59.81% | ||
| -80.02% | ||
| -12.45% | ||
| +61.32% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $1.13 | ||
| $1.58 | ||
| $1.35 | ||
| $1.47 | ||
| $1.35 | ||
| -$0.04 | ||
| 1.86 | ||
| $0.10 | ||
| 37.50 | ||
| 98.91% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $42.17M | ||
| -$1.45 | ||
| $28.36M | ||
| 57.94% | ||
| -$181.13M | ||
| -425.72% | ||
| -$183.12M | ||
| -434.23% | ||
| -$175.61M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.61 | ||
| 2.03 | ||
| 2.00 | ||
| - | ||
| 4 | ||
| -8.42 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 3.43 | ||
| 2.87 | ||
| -0.81 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $61.01M | ||
| $172.13M | ||
| $265.77M | ||
| $193.72M | ||
| $204.76M | ||
| $95.46M | ||
| $37.17M | ||
| $1.83M | ||
| $9.92M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $225.30M | ||
| $209.49M | ||
| $17.74M | ||
| $0.00 | ||
| $3.92M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$138.51M | ||
| $375.09M | ||
| -$273.71M | ||
| $0.00 | ||
| -$138.51M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Guggenheim | → | |
| Guggenheim | ||
| Oppenheimer | ||
| Maxim Group | → | |
| HC Wainwright & Co. | → | |
| UBS | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Baird | → |
Analyst sentiment
Institutional ownership
No data
Screeners with CHRS
FAQ
- What is the ticker symbol for Coherus Oncology, Inc.?
- The ticker symbol for Coherus Oncology, Inc. is NASDAQ:CHRS
- Does Coherus Oncology, Inc. pay dividends?
- No, Coherus Oncology, Inc. does not pay dividends
- What sector is Coherus Oncology, Inc. in?
- Coherus Oncology, Inc. is in the Healthcare sector
- What industry is Coherus Oncology, Inc. in?
- Coherus Oncology, Inc. is in the Biotechnology industry
- What country is Coherus Oncology, Inc. based in?
- Coherus Oncology, Inc. is headquartered in United States
- When did Coherus Oncology, Inc. go public?
- Coherus Oncology, Inc. initial public offering (IPO) was on November 6, 2014
- Is Coherus Oncology, Inc. in the S&P 500?
- No, Coherus Oncology, Inc. is not included in the S&P 500 index
- Is Coherus Oncology, Inc. in the NASDAQ 100?
- No, Coherus Oncology, Inc. is not included in the NASDAQ 100 index
- Is Coherus Oncology, Inc. in the Dow Jones?
- No, Coherus Oncology, Inc. is not included in the Dow Jones index
- When was Coherus Oncology, Inc. last earnings report?
- Coherus Oncology, Inc.'s most recent earnings report was on August 5, 2026
- When does Coherus Oncology, Inc. report earnings?
- The next expected earnings date for Coherus Oncology, Inc. is November 5, 2026
Data Sources & References
- CHRS Official Website www.coherus.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1512762/000110465926025308/0001104659-26-025308-index.htm
- CHRS Profile on Yahoo Finance finance.yahoo.com/quote/CHRS
- CHRS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/chrs